Hong Kong-Based Pharma Aptorum Seeks To Raise Up To $30M In US IPO

Hong Kong-based pharmaceutical company Aptorum Group Limited is seeking to raise up to US$30 million in an initial public offering of its class A ordinary shares in the U.S., according to a statement released by the company yesterday. According to the statement, Aptorum is planning to offer up to 1.89 million shares and up to 51,990 […]

Hong Kong-Based Pharma Aptorum Seeks To Raise Up To $30M In US IPO appeared first on China Money Network.

Read the original article: China Money Network